Obesity drug trial halted before it began
NCT ID NCT06970405
Summary
This was an early, withdrawn study to check the safety and basic effects of an experimental drug called garetosmab in otherwise healthy adults with obesity. It aimed to see how the body processes the drug and how it might affect hormone levels and blood clotting. No participants were enrolled before the study was stopped.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.